Bruce Robinson

Professor, MD W.Aust., DTM&H Liv., FRACP, FRCP

  • The University of Western Australia (M503), 35 Stirling Highway,

    6009 Perth

    Australia

  • 9682 Citations
  • 49 h-Index
1992 …2022
If you made any changes in Pure these will be visible here soon.

Personal profile

Roles and responsibilities

Consultant Physician, Respiratory medicine, Sir Charles Gardner Hospital
Research Scientist, Tumour Immunology Group, University of Western Australia. Regularly speaking at major international meetings & has made numerous media appearances relating to science.
Lectures, seminars and clinical teaching to 3rd-6th year medical students
Co-founder and Director of the National Centre for Asbestos Related Diseases [www.ncard.org], Chairs the State Health Research Advisory Council [www.shrac.health.wa.gov.au]
Co-founder and director of the International Skills and Training Institute in Health [www.istih.org], a philanthropic organization which provides services and training in disaster situations within the Asian region.

Teaching overview

35 years experience in teaching medical students, including new programs in communication skills [‘how to break bad news to patients'] and in medical research through lecturing, seminars and clinical teaching. He has also initiated teaching weekends and medical teacher development days. Winner of 3 UWA Medical School Teacher-of-the-Year awards.

Research

Co-leader of a large research team studying cancer immunology and asbestos diseases. The team have made many discoveries, including the first blood test for mesothelioma and have conducted many world-first treatments, including Australia's first cancer gene therapy trial.

Languages

Fluent:
English, Indonesian
Basic understanding:
Italian, French

Keywords

  • Cancer
  • Immunology
  • Respiratory medicine

Fingerprint Dive into the research topics where Bruce Robinson is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 43 Similar Profiles
Mesothelioma Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Asbestos Medicine & Life Sciences
T-Lymphocytes Medicine & Life Sciences
Immunotherapy Medicine & Life Sciences
Cross-Priming Medicine & Life Sciences
Neoplasm Antigens Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1992 2019

Identification of a CD8+ T-cell response to a predicted neoantigen in malignant mesothelioma

Sneddon, S., Rive, C. M., Ma, S., Dick, I. M., Allcock, R. J. N., Brown, S. D., Holt, R. A., Watson, M., Leary, S., Lee, Y. C. G., Robinson, B. W. S. & Creaney, J., 1 Jan 2019, In : OncoImmunology. 1684713.

Research output: Contribution to journalArticle

Open Access
T-Lymphocytes
Pleural Effusion
Neoplasms
Immunotherapy
Mutation
4 Citations (Scopus)

Immunotherapy strategies for mesothelioma–the role of tumor specific neoantigens in a new era of precision medicine

Ye, L., Ma, S., Robinson, B. W. & Creaney, J., 1 Feb 2019, In : Expert Review of Respiratory Medicine. 13, 2, p. 181-192 12 p.

Research output: Contribution to journalReview article

Precision Medicine
Immunotherapy
Mesothelioma
Neoplasms
Therapeutics
1 Citation (Scopus)

Inhibition of collagen production delays malignant mesothelioma tumor growth in a murine model

Abayasiriwardana, K. S., Wood, M. K., Prêle, C. M., Birnie, K. A., Robinson, B. W., Laurent, G. J., McAnulty, R. J. & Mutsaers, S. E., 5 Mar 2019, In : Biochemical and Biophysical Research Communications. 510, 2, p. 198-204 7 p.

Research output: Contribution to journalArticle

Tumors
Collagen
Mesothelioma
Growth
Neoplasms

Neo-antigen specific T cell responses indicate the presence of metastases before imaging

Fear, V. S., Forbes, C. A., Chee, J., Ma, S., Neeve, S., Celliers, L., Fisher, S. A., Dick, I., Creaney, J. & Robinson, B. W. S., 10 Oct 2019, In : Scientific Reports. 9, 1, 1 p.

Research output: Contribution to journalArticle

Open Access
Lung Diseases
Neoplasm Metastasis
T-Lymphocytes
Antigens
Histology

Pre-treatment tumor neo-antigen responses in draining lymph nodes are infrequent but predict checkpoint blockade therapy outcome

Ma, S., Chee, J., Fear, V. S., Forbes, C. A., Boon, L., Dick, I. M., Robinson, B. W. S. & Creaney, J., 1 Jan 2019, In : OncoImmunology. 1684714.

Research output: Contribution to journalArticle

Open Access
Neoplasm Antigens
Lymph Nodes
Antigens
Neoplasms
T-Lymphocytes

Projects 1996 2022